Investor Information
Ondine Biomedical Inc.
Life sciences company headquartered in Vancouver, Canada
Leading the charge in breakthrough photodisinfection-based therapies to prevent and treat a broad spectrum of infections, including those caused by superbugs
Focused on developing and commercializing novel antimicrobial therapies that address significant patient needs, are environmentally safe, provide substantial public health benefits, are easy to deploy, and cost a fraction of the infections they target.
For Media Information
Simon Vane Percy
+44 (0) 1737 82180
Amanda Bernard
- + 44 (0) 77763 73269